Profile
Jutta Poutanen formerly worked at Orion Pharma Oy, as Senior Research Scientist from 2005 to 2008, BioCis Pharma Oy, as Development Manager-Product Development, Laurantis Pharma Oy, as Chief Pharmaceutical Officer from 2011 to 2014, and Herantis Pharma Oyj, as Chief Pharmaceutical Officer from 2010 to 2021.
Ms. Poutanen received her graduate degree from the University of Helsinki.
Former positions of Jutta Poutanen
| Companies | Position | End |
|---|---|---|
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Corporate Officer/Principal | 31/03/2014 |
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Provides contract manufacturing services to the pharmaceutical sector | Corporate Officer/Principal | 31/07/2008 |
BioCis Pharma Oy
BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceutical products | Corporate Officer/Principal | - |
| HERANTIS PHARMA OYJ | Corporate Officer/Principal | - |
Training of Jutta Poutanen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Orion Pharma Oy
Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Provides contract manufacturing services to the pharmaceutical sector | Health Technology |
BioCis Pharma Oy
BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures novel pharmaceutical products | Health Technology |
University of Helsinki
University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Herantis Pharma Oyj
Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
- Stock Market
- Insiders
- Jutta Poutanen
















